icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Virtual
February 12-16, 2022
Back grey_arrow_rt.gif
 
 
 
ARCHIVED RESISTANCE AND RESPONSE TO <40 C/ML AND TND - DTG/3TC FDC AT WEEK 48 IN SALSA
 
 
  CROI Feb 11-16
 
Mark Underwood,1 Olayemi Osiyemi,2 Rafael Rubio,3 Laurent Hocqueloux,4 Norma Porteiro,5 Olaf Degen,6 James Oyee,7 Joe Horton,8 Chris Parry,9 Ruolan Wang,1 Myooran Sithamparanathan,9 Jean van Wyk,9 Brian Wynne,1 Choy Man,1 Elizabeth Blair1 1ViiV Healthcare, Research Triangle Park, NC, USA; 2Triple O Research Institute PA, West Palm Beach, FL, USA; 3Department of Internal Medicine, Hospital Universitario 12 de Octubre, UCM, Madrid, Spain; 4Centre Hospitalier Régional d’Orléans, Orléans, France; 5Fundacion IDEAA, Buenos Aires, Argentina; 6Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 7GlaxoSmithKline, Brentford, UK; 8Parexel International, Durham, NC, USA; 9ViiV Healthcare, Brentford, UK

0301221

0301222

0301223

0301224

0301225

0301226